LONG-TERM ENDOCRINE SEQUELAE AFTER COVID-19: CLINICAL INSIGHTS, DIGITAL HEALTH PERSPECTIVES AND PUBLIC HEALTH CHALLENGES
DOI:
https://doi.org/10.31435/ijitss.4(48).2025.4194Keywords:
COVID-19, Long COVID, Endocrine Dysfunction, Adrenal Insufficiency, Autoimmune Thyroiditis, Tele-EndocrinologyAbstract
The COVID-19 pandemic has revealed that SARS-CoV-2 infection affects not only the respiratory system but also multiple endocrine organs, leading to a broad spectrum of long-term hormonal disturbances. This narrative review aims to summarize the current evidence on endocrine sequelae after COVID-19, emphasizing pathophysiological mechanisms, clinical manifestations, and implications for patient management. A structured literature search was conducted in PubMed, Scopus, Web of Science, and Google Scholar for studies published between January 2020 and October 2025 addressing endocrine or metabolic consequences of COVID-19.
The reviewed data demonstrate that SARS-CoV-2 can impair the hypothalamic–pituitary–adrenal, thyroid, gonadal, pancreatic, and growth hormone axes through direct viral injury, immune-mediated inflammation, and chronic stress-axis dysregulation. Clinical consequences include secondary adrenal insufficiency, autoimmune thyroiditis, new-onset diabetes, hypogonadism, and menstrual disorders. While many abnormalities appear transient, a subset of patients develop persistent dysfunction requiring long-term follow-up.
Tele-endocrinology and digital health solutions have emerged as valuable tools for monitoring endocrine recovery and improving access to care. However, significant research gaps remain, particularly regarding long-term prevalence, reversibility, and mechanisms of endocrine injury. Understanding and addressing these complications will require coordinated, multidisciplinary strategies that integrate clinical endocrinology, public health, and digital innovation.
References
Szczerbiński, Ł., Okruszko, M. A., Szabłowski, M., Sołomacha, S., Sowa, P., Kiszkiel, Ł., Gościk, J., Krętowski, A. J., Moniuszko-Malinowska, A., & Kamiński, K. (2023). Long-term effects of COVID-19 on the endocrine system – A pilot case-control study. Frontiers in Endocrinology, 14, 1192174. https://doi.org/10.3389/fendo.2023.1192174
Pal, R., Joshi, A., Bhadada, S. K., Banerjee, M., Vaikkakara, S., & Mukhopadhyay, S. (2022). Endocrine follow-up during post-acute COVID-19: Practical recommendations based on available clinical evidence. Endocrine Practice, 28(4), 425–432. https://doi.org/10.1016/j.eprac.2022.02.003
Clarke, S. A., Abbara, A., & Dhillo, W. S. (2022). Impact of COVID-19 on the endocrine system: A mini-review. Endocrinology, 163(1), bqab203. https://doi.org/10.1210/endocr/bqab203
Esmaeilzadeh, A., Elahi, R., Siahmansouri, A., Maleki, A. J., & Moradi, A. (2022). Endocrine and metabolic complications of COVID-19: Lessons learned and future prospects. Journal of Molecular Endocrinology, 69(3), R125–R150. https://doi.org/10.1530/JME-22-0036
Iosef, C., Matusa, A. M., Han, V. K. M., & Fraser, D. D. (2024). Endocrine dysregulation in COVID-19: Molecular mechanisms and insights. Frontiers in Endocrinology, 15, 1459724. https://doi.org/10.3389/fendo.2024.1459724
Panesar, A., Gharanei, P., Khovanova, N., Young, L., & Grammatopoulos, D. (2025). Thyroid function during COVID-19 and post-COVID complications in adults: A systematic review. Frontiers in Endocrinology, 15, 1477389. https://doi.org/10.3389/fendo.2024.1477389
Anbardar, N., Dixon, S. L., Munugoti, S., Gaddam, M., Kashfi, K., Kasulis, L., Messersmith, A. L., & Asadipooya, K. (2025). Thyroid disorders and COVID-19: A comprehensive review of literature. Frontiers in Endocrinology, 16, 1535169. https://doi.org/10.3389/fendo.2025.1535169
Nakano, Y., Sunada, N., Tokumasu, K., et al. (2024). Occult endocrine disorders newly diagnosed in patients with post-COVID-19 symptoms. Scientific Reports, 14, 5446. https://doi.org/10.1038/s41598-024-55526-3
Kanczkowski, W., Beuschlein, F., & Bornstein, S. R. (2022). Is there a role for the adrenal glands in long COVID? Nature Reviews Endocrinology, 18, 451–452. https://doi.org/10.1038/s41574-022-00700-8
Sahoo, S. K., Menon, J. C., Tripathy, N., Nayak, M., & Yadav, S. (2024). Reversible central adrenal insufficiency in survivors of COVID-19: Results from a 24-month longitudinal study. Endocrine Connections, 13(9), e240086. https://doi.org/10.1530/EC-24-0086
Porntharukchareon, T., Dechates, B., Sirisreetreerux, S., Therawit, P., & Tawinprai, K. (2024). The existence of adrenal insufficiency in patients with COVID-19 pneumonia. Frontiers in Endocrinology, 15, 1337652. https://doi.org/10.3389/fendo.2024.1337652
Alijotas-Reig, J., Anunciacion-Llunell, A., Esteve-Valverde, E., Morales-Pérez, S., Rivero-Santana, S., Trapé, J., González-García, L., Ruiz, D., Marques-Soares, J., & Miro-Mur, F. (2024). Pituitary-adrenal axis and peripheral immune cell profile in long COVID. Biomedicines, 12(3), 581. https://doi.org/10.3390/biomedicines12030581
Di Filippo, L., Franzese, V., Santoro, S., Doga, M., & Giustina, A. (2024). Long COVID and pituitary dysfunctions: A bidirectional relationship? Pituitary, 27(6), 955–969. https://doi.org/10.1007/s11102-024-01442-8
Taieb, A., Ben Haj Slama, N., Gorchane, A., Ben Abdelkrim, A., Garma, M., Ben Lasfar, N., Bellazreg, F., Debbabi, W., Hachfi, W., Chadli Chaieb, M., Zaouali, M., Letaief, A., & Ach, K. (2024). Explaining long COVID: A pioneer cross-sectional study supporting the endocrine hypothesis. Journal of the Endocrine Society, 8(3), bvae003. https://doi.org/10.1210/jendso/bvae003
Kim, S. H., Arora, I., Hsia, D. S., Knowler, W. C., LeBlanc, E., Mylonakis, E., Pratley, R., & Pittas, A. G. (2023). New-onset diabetes after COVID-19. The Journal of Clinical Endocrinology & Metabolism, 108(11), e1164–e1174. https://doi.org/10.1210/clinem/dgad284
Li, J., Li, Y., Wang, Z., Liu, N., He, L., & Zhang, H. (2023). Increased risk of new-onset diabetes in patients with COVID-19: A systematic review and meta-analysis. Frontiers in Public Health, 11, 1170156. https://doi.org/10.3389/fpubh.2023.1170156
He, X., Liu, C., Peng, J., et al. (2021). COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors. Signal Transduction and Targeted Therapy, 6, 427. https://doi.org/10.1038/s41392-021-00822-x
Anastácio, B. M., Monteiro, P. B., & Capelo, M. F. (2024). The impact of COVID-19 on male reproductive health: A systematic review. JBRA Assisted Reproduction, 28(3), 483–488. https://doi.org/10.5935/1518-0557.20240028
Alzahrani, M. A., Alkhani, K. O., Alassaf, A. M., Alorainy, J. I., Binsaleh, S., & Almannie, R. (2024). Updates in the pathophysiology of COVID-19 infection in male reproductive and sexual health: A literature review. Frontiers in Endocrinology, 14, 1226858. https://doi.org/10.3389/fendo.2023.1226858
Maybin, J. A., Walker, C., Watters, M., et al. (2025). The potential bidirectional relationship between long COVID and menstruation. Nature Communications, 16, 8187. https://doi.org/10.1038/s41467-025-62965-7
Koch, C. A. (2024). Long COVID: Hormone imbalances and/or rather complex immune dysregulations? Journal of the Endocrine Society, 8(5), bvae043. https://doi.org/10.1210/jendso/bvae043
Bansal, R., Gubbi, S., & Koch, C. A. (2022). COVID-19 and chronic fatigue syndrome: An endocrine perspective. Journal of Clinical & Translational Endocrinology, 27, 100284. https://doi.org/10.1016/j.jcte.2021.100284
SeyedAlinaghi, S., Yarmohammadi, S., Mirzapour, P., Dehghani, S., Ahmadi, S., Abbaspour, F., Pashaei, A., Molla, A., & Mehraeen, E. (2024). A systematic review of telehealth applications in endocrinology. Telemedicine Reports, 5(1), 269–289. https://doi.org/10.1089/tmr.2024.0032
Zupa, M., Hamm, M., Alexander, L., & Rosland, A. M. (2025). Patient and clinician perspectives on the effectiveness of current telemedicine approaches in endocrinology care for type 2 diabetes: A qualitative study. JMIR Diabetes, 10, e60765. https://doi.org/10.2196/60765
Puig-Domingo, M., Marazuela, M., & Giustina, A. (2020). COVID-19 and endocrine diseases: A statement from the European Society of Endocrinology. Endocrine, 68(1), 2–5. https://doi.org/10.1007/s12020-020-02294-5
Clarke, S. A., Abbara, A., & Dhillo, W. S. (2022). COVID-19 and endocrine function. Endocrinology, 163(1), bqab203. https://doi.org/10.1210/endocr/bqab203
Lundholm, M. D., Poku, C., Emanuele, N., Emanuele, M. A., & Lopez, N. (2020). SARS-CoV-2 (COVID-19) and the endocrine system. Journal of the Endocrine Society, 4(11), bvaa144. https://doi.org/10.1210/jendso/bvaa144
Downloads
Published
Issue
Section
License
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
